Dietary supplements have become very popular worldwide because they are believed to be safe with few side ef-
Introduction
Dietary supplements are widely used throughout the world because they are assumed to be harmless compared with conventional drugs. However, hepatotoxicity due to dietary supplements has been increasingly recognized (1) . We report here three cases of liver injury caused by Sennomotokounou, a Chinese dietary supplement. This popularly used supplement for weight reduction in Japan was recently removed from the market because of its hepatotoxic adverse reactions.
Case Report Case1 A 63-year-old Japanese womanpresented with a 2-week history of jaundice.
She had taken Sennomotokounou for 6 weeks. On examination, she was icteric without fever or A liver biopsy performed two months after withdrawal of dietary product showed mild hepatocellular steatosis and drop-out in the centrilobular areas (Fig. 2) . The histological findings were consistent with those of drug-induced liver injury.
Case2
A 24-year-old Japanese womanpresented with a oneweek history of jaundice and appetite loss. She had taken are not pressured to ensure that the product label information is truthful and not misleading. In addition, a commonmisconception is that dietary supplements are harmless compared with conventional drugs. Because of these conditions, the hepatotoxicity of dietary supplements has been increasingly recognized (1). We report three healthy people who developed hepatotoxicity while taking Sennomotokounou, a Chinese dietary supplement marketed for weight loss. The clinical summary is presented in Table 1 . All patients had taken the supplement for 4 to 6 weeks. Cases 1 and 2 presented with symptoms and liver dysfunction characteristic of acute hepatitis, while case 3 represented the recovery stage of acute hepatitis.
There was no evidence of allergies, such as rashes or eosinophilia.
The The relative importance of each component is weighed, and arbitrary scores are attributed. The probability of the diagnosis of drug-induced liver injury is expressed as a final score, and is graded as either definite drug hepatotoxicity (score >17), probable (14-17), unlikely (6-9), or drug hepatotoxicity excluded (<6). As for the present cases, according to this scoring system, all On the other hand, fenfluramine is an amphetamine derivative which blocks serotonin uptake, provoking transport-mediated serotonin release. It was popularly used as an anoretic agent in Western Europe and North America previously (4). The use of fenfluramine is prohibited because primary pulmonary hypertension, valvular heart disease and neurotoxicity are associated with its use (5-8). As for hepatotoxicity, there is only one report of fatal hepatitis after taking herbal medicine and dexfenfluramine, which is a dextro-isomer of fenfluramine (9). The manufacturer of Sennomotokounou probably used n-nitroso-fenfluramine as an anorexic agent instead of fenfluramine because the use of fenfluramine is illegal.
Several nitroso-compounds are well known to induce hepatic injury in animals (10). Recently, the NIHS reported that n-nitrosofenfluramine induced hepatic injury in experimental animals (ref. for the observed hepatotoxicity. These include toxic effects related to interactions of the ingredients in the product, such as trigger and potentiation.
Various factors may explain these interactions, including the induction of certain enzymes or formation of secondary toxic metabolites due to alterations in pharmacokinetic and pharmacodynamic properties of certain ingredients.
Alternatively, a pharmacogenetic predisposition may contribute to Sennomotokounou-induced hepatotoxicity.
Hyperthyroidism should be considered as another serious side effect of Sennomotokounou, which contains thyroid hormones, mainly T3. In the present cases, the serum TSH level was suppressed with normal serum free thyroid hormone levels. If thyroid function had been evaluated immediately after drug withdrawal, serum thyroid hormone levels would have been elevated.
Hepatic dysfunction is often observed in patients with hyperthyroidism. Jaundice may be due to congestive heart failure as a complication of thyrotoxicosis and aggravation of an underlying defect in serum bilirubin metabolism, such as Gilbert's syndrome
(1 1). Hepatobiliary enzymes may also increase mildly in patients with uncomplicated hyperthyroidism (12, 13). In our cases, the abnormal liver test results were not typical of the pattern of hepatic dysfunction observed in hyperthyroidism. Although there is no evidence of direct hepatotoxic effects due to thyroid hormones, it is known that they sensitize the liver to some hepatotoxicants (14-1 6). Hyperthyroidism may 
